Invesaro

Stocks LFCR Earnings

Earnings

Lifecore Biomedical, Inc. DE (LFCR) earnings

Quarterly results of Lifecore Biomedical, Inc. DE as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when LFCR files with the SEC.

Next earnings date

Lifecore Biomedical, Inc. DE is expected to report around March 15, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Lifecore Biomedical, Inc. DE reported revenue of $25.3M (-28% on the same quarter a year earlier) and a net loss of $40.1M.

Diluted earnings per share were -$1.08.

Filed with the SEC on November 4, 2026.

Revenue by quarter
Q1 25: $24.7M $24.7M Q1 25Q2 25: $32.6M $32.6M Q2 25Q3 25: $35.2M $35.2M Q3 25Q4 25: $36.4M $36.4M Q4 25Q1 26: $31.1M $31.1M Q1 26Q1 26: $23.2M $23.2M Q1 26Q2 26: $34.2M $34.2M Q2 26Q3 26: $25.3M $25.3M Q3 26
Net income by quarter
Q1 25: -$16.2M -$16.2M Q1 25Q2 25: -$6.6M -$6.6M Q2 25Q3 25: -$14.8M -$14.8M Q3 25Q4 25: -$1.1M -$1.1M Q4 25Q1 26: -$10M -$10M Q1 26Q1 26: -$15M -$15M Q1 26Q2 26: -$6.2M -$6.2M Q2 26Q3 26: -$40.1M -$40.1M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026$25.3M-28%-$40.1M-$1.08
Q2 FY2026June 30, 2026$34.2M+4.9%-$6.2M-$0.19
Q1 FY2026March 31, 2026$23.2M-6.1%-$15M-$0.43
Q1 FY2026September 30, 2025$31.1M+25.9%-$10M-$0.29
Q4 FY2025May 25, 2025$36.4M--$1.1M-$0.06
Q3 FY2025February 23, 2025$35.2M--$14.8M-$0.42
Q2 FY2025November 24, 2024$32.6M--$6.6M-$0.25
Q1 FY2025August 25, 2024$24.7M--$16.2M-$0.53

Results filings

When is Lifecore Biomedical, Inc. DE's next earnings date?

Lifecore Biomedical, Inc. DE is expected to report around March 15, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Lifecore Biomedical, Inc. DE's latest quarterly results?

For Q3 FY2026, which ended September 30, 2026, Lifecore Biomedical, Inc. DE reported revenue of $25.3M and a net loss of $40.1M. The figures come from its filing with the SEC.

Is Lifecore Biomedical, Inc. DE's revenue growing?

Revenue in Q3 FY2026 was $25.3M, down 28% from $35.2M in the same quarter a year earlier.

Get an email when LFCR reports

Follow LFCR and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when LFCR files with the SEC.

Source: quarterly figures Lifecore Biomedical, Inc. DE tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Lifecore Biomedical, Inc. DE